My PCR
Create Account
Logo PCR

16 May 2024

Trial updates and featured clinical research

Session comprising selected EuroPCR 2024 Abstract submissions

Facilitators: M. C. Morice, A. Witkowski
Discussants: A. Abizaid, S. Redwood
SHOW MORE

Summary

This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual antiplatelet therapy regimens with biodegradable polymer and durable polymer drug-eluting stents, the role of fractional flow reserve in left ventricular dysfunction, and the long-term outcomes of renal denervation. The session aims to provide interventional cardiologists with insights into the evolving evidence and its implications for clinical practice.

Presentations available when logged in:

  • OCT-guided PCI for CTOs: an ILUMIEN IV substudy
  • One-month DAPT after biodegradable-polymer everolimus-eluting stent in high-bleeding risk patients
  • Does QFR predict ischemia in left ventricular dysfunction?
  • Outcomes according to coronary disease complexity and optimal thresholds to guide revascularisation
  • Safety and efficacy of Supraflex Cruz DES in high bleeding risk patients receving and short DAPT regimen
  • Pooled, long-term analysis of the global symplicity clinical trial program of radiofrequency RDN
  • Patient-reported outcomes from the ENVISAGE-TAVI AF trial using the win ratio analysis